Hansoh Pharmaceutical Group Company Limited (HKG:3692)
39.20
+0.46 (1.19%)
Apr 24, 2026, 2:05 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 234.88 billion as of April 23, 2026. Its market cap has increased by 67.71% in one year.
Market Cap
234.88B
Enterprise Value
199.87B
Revenue
16.72B
Ranking
n/a
PE Ratio
37.47
Stock Price
39.20
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 234.88B, an increase of 111.10%. That is a compound annual growth rate of 11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 234.88B | 7.53% |
| Dec 31, 2025 | 218.43B | 113.01% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 38.57B |
| China Medical System Holdings | 33.52B |
| Simcere Pharmaceutical Group | 33.06B |
| Sunshine Lake Pharma | 25.78B |
| Grand Pharmaceutical Group | 22.90B |
| The United Laboratories International Holdings | 19.73B |
| Fujian Haixi Pharmaceuticals | 15.19B |
| CanSino Biologics | 13.50B |